Stabilization of neurotoxic soluble beta-sheet-rich conformations of the Alzheimer's disease amyloid-beta peptide.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Biophysical Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 18065467PMCID PMC2267149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Secondary structure and interfacial aggregation of amyloid-beta(1-40) on sodium dodecyl sulfate micelles.

  2006cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics

  2006cited by this paper
• Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42

  2005cited by this paper
• What is the dominant Abeta species in human brain tissue? A review.

  2005cited by this paper
• Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.

  2005cited by this paper
• Mechanism of thioflavin T binding to amyloid fibrils.

  2005cited by this paper
• DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data

  2004cited by this paper
• Residues 17–20 and 30–35 of beta‐amyloid play critical roles in aggregation

  2004cited by this paper
• Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β‐amyloid

  2004cited by this paper
• Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Aβ peptides

  2004cited by this paper
• Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

  2003cited by this paper
• Neurotoxic, Redox-competent Alzheimer's β-Amyloid Is Released from Lipid Membrane by Methionine Oxidation*

  2003cited by this paper
• Spontaneous aggregation and cytotoxicity of the beta-amyloid Abeta1-40: a kinetic model.

  2003cited by this paper
• Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways.

  2003cited by this paper
• A slowly formed transient conformer of Abeta(1-40) is toxic to inward channels of dissociated hippocampal and cortical neurons of rats.

  2003cited by this paper
• The metallobiology of Alzheimer's disease.

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability*

  2002cited by this paper
• DICHROWEB: an interactive website for the analysis of protein secondary structure from circular dichroism spectra

  2002cited by this paper
• Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy

  2001cited by this paper
• A simple way to measure protein refolding rates in water.

  2001cited by this paper
• Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

  2001cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

  2001cited by this paper
• Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains.

  2000cited by this paper
• Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells.

  2000cited by this paper
• Metals and neuroscience.

  2000cited by this paper
• Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.

  2000cited by this paper
• Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc.

  2000cited by this paper
• Amyloidogenicity and neurotoxicity of peptides corresponding to the helical regions of PrPC

  2000cited by this paper
• Histochemically Reactive Zinc in Plaques of the Swedish Mutant β-Amyloid Precursor Protein Transgenic Mice

  1999cited by this paper
• The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.

  1999cited by this paper
• Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons

  1999cited by this paper
• Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion*

  1999cited by this paper
• Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

  1999cited by this paper
• Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.

  1999cited by this paper
• Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

  1998cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Copper, iron and zinc in Alzheimer's disease senile plaques.

  1998cited by this paper
• Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?

  1998cited by this paper
• Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity.

  1998cited by this paper
• Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

  1997cited by this paper
• Observation of metastable Abeta amyloid protofibrils by atomic force microscopy.

  1997cited by this paper
• Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.

  1996cited by this paper
• Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

  1996cited by this paper
• Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay*

  1996cited by this paper
• Perturbation of a tertiary hydrogen bond in barstar by mutagenesis of the sole His residue to Gln leads to accumulation of at least one equilibrium folding intermediate.

  1995cited by this paper
• The program XEASY for computer-supported NMR spectral analysis of biological macromolecules

  1995cited by this paper
• Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress.

  1995cited by this paper
• NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment.

  1992cited by this paper
• Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene

  1992cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper
• A new method for determining the heat capacity change for protein folding.

  1989cited by this paper
• Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants.

  1988cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Neutron diffraction of alpha, beta and gamma cyclodextrins: hydrogen bonding patterns.

  1984cited by this paper
• Estimation of globular protein secondary structure from circular dichroism.

  1981cited by this paper
• The effect of salts on the critical concentration for the formation of micelles in colloidal electrolytes.

  1947cited by this paper

• N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research

  2025cites this paper
• Diagnosis and therapy of Alzheimer's disease: Light-driven heterogeneous redox processes.

  2024cites this paper
• Protein Aggregation and its Affecting Mechanisms in Neurodegenerative Diseases.

  2024cites this paper
• MAPT mutations associated with familial tauopathies lead to formation of conformationally distinct oligomers that have cross‐seeding ability

  2024cites this paper
• Edge Substitution Effects of Histidine Tautomerization Behaviors on the Structural Properties and Aggregation Properties of Aβ(1-42) Mature Fibril.

  2024cites this paper
• The effect of histidine behaviors on the structural properties of Aβ(1-42) peptide in protonation stage one, two, and three.

  2023cites this paper
• Introducing Aliphatic Fluoropeptides: Perspectives on Folding Properties, Membrane Partition and Proteolytic Stability.

  2023cites this paper
• Sunset Yellow Dye Induces Amorphous Aggregation in β-Lactoglobulin at Acidic pH: A Multi-Techniques Approach

  2022cites this paper
• Mucin-Type O-Glycosylation Proximal to β-Secretase Cleavage Site Affects APP Processing and Aggregation Fate

  2022cites this paper
• Amyloid-β aggregates induced by β-cholesteryl glucose-embedded liposomes.

  2022cites this paper
• Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer’s Disease

  2022cites this paper
• Characterization of Homogeneous and Heterogeneous Amyloid-β42 Oligomer Preparations with Biochemical Methods and Infrared Spectroscopy Reveals a Correlation between Infrared Spectrum and Oligomer Size

  2021cites this paper
• Copper (Cu2+) ion-induced misfolding of tau protein R3 peptide revealed by enhanced molecular dynamics simulation.

  2021cites this paper
• Molecular insight into the early stage of amyloid-β(1-42) Homodimers aggregation influenced by histidine tautomerism.

  2021cites this paper
• Structural biology of cell surface receptors implicated in Alzheimer’s disease

  2021cites this paper
• Modular self-assembly of gamma-modified peptide nucleic acids in organic solvent mixtures

  2020cites this paper
• Salen-based bifunctional chemosensor for copper (II) ions: Inhibition of copper-induced amyloid-β aggregation.

  2020cites this paper
• Aβ(1-42) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage

  2020influential citation
• Hybrid molecules based on 1,3,5‐triazine as potential therapeutics: A focused review

  2020cites this paper
• Visualizing and trapping transient oligomers in amyloid assembly pathways

  2020cites this paper
• Alleviation of symptoms of Alzheimer's disease by diminishing Aβ neurotoxicity and neuroinflammation† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9sc03042e

  2019cites this paper
• Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.

  2019cites this paper
• Highly sensitive aptasensor based on interferometric reflectance spectroscopy for the determination of amyloid β as an Alzheimer's disease biomarkers using nanoporous anodic alumina.

  2019cites this paper
• Effects of Cu(II) on the aggregation of amyloid-β

  2019cites this paper
• Basified Human Lysozyme: A Potent Inhibitor against Amyloid β-Protein Fibrillogenesis.

  2018cites this paper
• Central β-turn increases the cell selectivity of imperfectly amphipathic α-helical peptides.

  2018cites this paper
• Preparation of a Well-Defined and Stable β-Barrel Pore-Forming Aβ42 Oligomer.

  2018cites this paper
• Amyloid Proteins

  2018cites this paper
• Aβ under stress: the effects of acidosis, Cu2+-binding, and oxidation on amyloid β-peptide dimers.

  2018cites this paper
• Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade.

  2018cites this paper
• Inhibition of lysozyme amyloidogenesis by phospholipids. Focus on long-chain dimyristoylphosphocholine.

  2017cites this paper
• Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions

  2017cites this paper
• Investigation of the multi-domain aggregation mechanism of ataxin-3

  2017cites this paper
• Influence of Conventional Surfactants on the Self-Assembly of a Bola Type Amphiphilic Peptide.

  2017cites this paper
• Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.

  2017cites this paper
• Interaction of the amyloid β peptide with sodium dodecyl sulfate as a membrane-mimicking detergent

  2016cites this paper
• ‘From past to future’ – deciphering the molecular basis of Alzheimer's disease through the pages of the Journal of Neurochemistry

  2016cites this paper
• A generic class of amyloid fibril inhibitors.

  2015cites this paper
• N-terminal microdomain peptide from human dihydroorotate dehydrogenase: structure and model membrane interactions.

  2015cites this paper
• Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study[S]

  2015cites this paper
• Conformational Behavior and Aggregation of Ataxin-3 in SDS

  2013cites this paper
• Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples

  2013cites this paper
• Charged surfactants induce a non‐fibrillar aggregation pathway of amyloid‐beta peptide

  2013cites this paper
• Untangling amyloid-β, tau, and metals in Alzheimer's disease.

  2013cites this paper
• Antioxidant role of amyloid β protein in cell-free and biological systems: implication for the pathogenesis of Alzheimer disease.

  2013cites this paper
• Amyloid-β peptide (1-42) aggregation induced by copper ions under acidic conditions.

  2013cites this paper
• In Vivo and Ex Vivo Imaging of Amyloid-β Cascade Aggregates with a Pronucleon™ Peptide

  2013cites this paper
• Bifunctional compounds for controlling metal-mediated aggregation of the aβ42 peptide.

  2012cites this paper
• Hydrophobicity and conformational change as mechanistic determinants for nonspecific modulators of amyloid β self-assembly.

  2012cites this paper
• Copper and oxidative stress in the pathogenesis of Alzheimer's disease.

  2012cites this paper
• Dual-function triazole-pyridine derivatives as inhibitors of metal-induced amyloid-β aggregation.

  2012cites this paper
• Amyloid β-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer's disease process and treatment.

  2012cites this paper
• Role of aromatic side chains in amyloid β-protein aggregation.

  2012cites this paper
• Inhibition of beta-amyloid peptide aggregation by multifunctional carbazole-based fluorophores.

  2012cites this paper
• Peptide-surfactant interactions: consequences for the amyloid-beta structure.

  2012cites this paper
• Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer’s disease

  2012influential citation
• Polythiophenes Inhibit Prion Propagation by Stabilizing Prion Protein (PrP) Aggregates*

  2012cites this paper
• Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity.

  2011cites this paper
• Structural preferences of Aβ fragments in different micellar environments.

  2011cites this paper
• Conformational diseases: structural studies of aggregation of polyglutamine proteins.

  2011cites this paper
• Creation of Aggregation‐Defective α‐Synuclein Variants by Engineering the Sequence Connecting β‐Strand‐Forming Domains

  2011cites this paper
• Crocetin inhibits beta-amyloid fibrillization and stabilizes beta-amyloid oligomers.

  2011cites this paper
• Studies to understand the effect of Centella asiatica on Aβ(42) aggregation in vitro

  2010cites this paper
• Spectroscopic Characterization of Intermolecular Interaction of Amyloid β Promoted on GM1 Micelles

  2010cites this paper
• DHPC strongly affects the structure and oligomerization propensity of Alzheimer's Aβ(1-40) peptide.

  2010cites this paper
• Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio

  2010cites this paper
• Detergent-like interaction of Congo red with the amyloid beta peptide.

  2010cites this paper
• Survey of the year 2008: applications of isothermal titration calorimetry

  2010cites this paper
• Amyloid formation in surfactants and alcohols: membrane mimetics or structural switchers?

  2010cites this paper
• Amyloid fibrillation and cytotoxicity of insulin are inhibited by the amphiphilic surfactants.

  2010cites this paper
• The chemistry of Alzheimer's disease.

  2009cites this paper
• Mechanism of zinc(II)-promoted amyloid formation: zinc(II) binding facilitates the transition from the partially α-helical conformer to aggregates of amyloid β protein(1–28)

  2009cites this paper
• Quantitative Reverse-Transcription Polymerase Chain Reaction Analysis of Alzheimer's-Associated Genes in Mouse Scrapie

  2009cites this paper
• Real-Time Imaging and Quantification of Amyloid-β Peptide Aggregates by Novel Quantum-Dot Nanoprobes

  2009influential citation
• Surfactant-induced conformational transition of amyloid β-peptide

  2009cites this paper
• Tetracycline and its Analogues as Drugs Against Protein Aggregation and Amyloid Formation

  2009cites this paper
• Copper and Zinc Binding to Amyloid‐β: Coordination, Dynamics, Aggregation, Reactivity and Metal‐Ion Transfer

  2009cites this paper
• Amphotericin B interactions with soluble oligomers of amyloid Abeta1-42 peptide.

  2009cites this paper
• Pharmacotherapeutic targets in Alzheimer's disease

  2008cites this paper
• Secondary structure transitions and aggregation induced in dynorphin neuropeptides by the detergent sodium dodecyl sulfate.

  2008cites this paper
• Secondary structure conversions of Alzheimer’s Aβ(1–40) peptide induced by membrane‐mimicking detergents

  2008cites this paper
• Membrane-targeted strategies for modulating APP and Aβ-mediated toxicity

  2008cites this paper